Botanical species · safety record

Nasturtium officinale

The EFSA Compendium of Botanicals holds 4 constituent measurements and 1 adverse-effect record for Nasturtium officinale. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Nasturtium officinale R.Br.

4Constituent measurements

1Safety records

4Cited sources

192Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 192 licensed products naming Nasturtium officinale as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Fresh

Source material stated

Aerial parts
Aerial parts extract
Fresh above ground parts
Fresh aerial part collected at flowering time
Herb
Herb top
Herb(s)
Leaf

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gluconasturtiin	Seed	Solvent extraction	54 Millimole/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Alkaloids	Live plants	Solvent extraction	—	Unspecified	No resolvable identifier
Glucosinolates	Leaves	Solvent extraction	≤ 570.3 Microgram/gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Glucosinolates	Leaves	Solvent extraction	≥ 293.2 Microgram/gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Uterus	Unspecified	Solvent extraction	Rat (as animal)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Han, Hyejung., Kwon, Hoonjeong. Estimated dietary intake of thiocyanate from Brassicaceae family in Korean diet. Journal of toxicology and environmental health, part a: current issues, 2009, p. 1380-1387.
Zalackas, C. Antidote to nicotine. comptes rendus hebdomadaires des seances de l'academie des sciences, 1905, p. 741-742.
Williams, David J., Critchley, Christal., Pun, Sharon., Chaliha, Mridusmita., O'Hare, Timothy J. Differing mechanisms of simple nitrile formation on glucosinolate degradation in Lepidium sativum and Nasturtium officinale seeds . Phytochemistry, 2009, vol. 70, no. 11-12, p. 1401-1409. DOI
Elbetieha, A., Al-Hamood, M.H., Alkofahi, A. Anti-implantation potential of some medicinal plants in female rats. Archives of std/hiv research, 1996, vol. 10, no. 3, p. 181-188.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature